Lais Lopes Pires

Lais Lopes Pires

Auto-generated profile, based on publicly available information

Lais Lopes Pires

Complexo Hospital de Niterói, Niterói, RJ, Brazil

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Clinics
Verified
Journal Article
Open access
MGMariana Fernandes Guimarães
Mariana Fernandes Guimarães
KLKathryn Lynn Lovero
Kathryn Lynn Lovero
JAJuliana Gregório de Avelar
Juliana Gregório de Avelar
LPLaís Lopes Pires
Laís Lopes Pires
GOGiovanna Rodrigues Teixeira de Oliveira
Giovanna Rodrigues Teixeira de Oliveira
CCClaudete Cardoso
Claudete Cardoso
The present literature review aims to highlight gaps in the treatment of preventative mother-to-child HIV transmission and the risk factors in Brazil. Among the 425 articles identified in SciELO and PubMed searches, 59 articles published between 1994 and 2016 were selected for reading and data extraction, and 33 articles were included in the present review. The rates of vertical HIV transmission described in the studies varied widely, from 1.8% to 27.8%, with a significant reduction over the years. However, recent rates were also found to be variable in different regions of Brazil, and despite the significant reduction in mother-to-child transmission, many gaps remain in prevention services. A failure to attend prenatal care is the main factor associated with the increased risk of vertical transmission of HIV, hindering early maternal diagnosis and the completion of preventative measures during the prenatal period and, often, the peripartum and postnatal periods. A small number of studies discussed the sociodemographic factors, including a low level of education for pregnant women and the inadequacies of health services, such as difficulties scheduling appointments and undertrained staff, associated with vertical transmission. As such, the current challenge is to better define the sociodemographic and infrastructural factors that increase the risk of mother-to-child transmission of HIV to provide the necessary investments to promote an earlier inclusion of these populations in prevention services. This review may serve as a guide for future programs to focus efforts on the prevention of vertical HIV transmission.

1 November 2022 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
TRTayla Taynan Romão
Tayla Taynan Romão
AAAbraão Iuri Medeiros Angelim
Abraão Iuri Medeiros Angelim
HPHenrique Jannuzzelli Pires Do Prado
Henrique Jannuzzelli Pires Do Prado
FGFernanda Veiga de Goes
Fernanda Veiga de Goes
MPMaria Elisa Paiva Pires
Maria Elisa Paiva Pires
IDIsabella D'ANdrea-Meira
Isabella D'ANdrea-Meira
Background Lacosamide (LCM) is a third-generation anti-seizure drug approved in Europe and the United States, either as a monotherapy or adjunctive therapy, to treat partial-onset seizures in adults, adolescents, and children. In Brazil, LCM is licensed for treatment only in patients older than 16 years of age. Objective To evaluate a cohort of children presenting with refractory epilepsy who received LCM as an add-on therapy and observe the response and tolerability to the LCM treatment. Methods A retrospective cohort study conducted in a tertiary health care facility, which included 26 children, aged up to 16 years, who presented with refractory epilepsy and received LCM as an add-on treatment. The follow-up visits were scheduled every 3 months until 9 months of treatment with LCM. Results After 3 months of LCM administration, in 73.1% of the children, there was a reduction of > 50% in the frequency of seizures, and this clinical improvement was maintained in most patients (73.9%) for the following 9 months. Mild (such as, somnolence and behavioral changes) or severe (seizure worsening) adverse effects were observed in two and three children respectively. Among responders to LCM, there was a higher prevalence of males, fewer concomitant anti-seizure drugs, and lower percentage of patients using sodium channel blockers. Conclusions Lacosamide should be considered as an early treatment option in pediatric patients with refractory epilepsy, mainly focal seizures.

7 April 2025 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
LPLais Lopes Pires
Lais Lopes Pires
MTMayara Gabriele Toledo
Mayara Gabriele Toledo
HAHugo Rodrigues Alves
Hugo Rodrigues Alves
ICIsadora Cambruzzi
Isadora Cambruzzi
GRGuilherme Brezenski Rodrigues
Guilherme Brezenski Rodrigues
NSNatalia Chilinque Zambão da Silva
Natalia Chilinque Zambão da Silva
Fungal infections have become a public health problem owingdute to their progressive increase in recent decades and high morbidity rates. Fungal bone and joint infections result from direct inoculation, contiguous infection spread, or hematogenous seeding of organisms. Trichosporon spp. are yeast-like basidiomycetes, with Trichosporon asahii being the most common pathogenic species. This article describes a rare case of tenosynovitis caused by Trichosporon asahii in an immunocompetent patient. Treatment with voriconazole resulted in an excellent clinical response. Tenosynovitis caused by